Pharmac has added the weight-loss drug Wegovy to its list of medicines for potential future funding, with eligibility for people with high BMI and comorbidities, raising hopes for broader access and potential healthcare cost savings.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 1 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
international price drops expected soon
Funding of weight-loss drug Wegovy expected to come swiftlySpotted something wrong on this page? Report a correction.